| 6.3 |
50.6 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 4.8 |
14.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 4.8 |
14.3 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 4.6 |
13.7 |
GO:2000412 |
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
| 4.6 |
18.2 |
GO:0002540 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 4.2 |
29.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 4.2 |
12.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 4.0 |
12.0 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 3.9 |
11.7 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 3.8 |
26.8 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 3.8 |
22.9 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 3.8 |
11.3 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 3.6 |
14.2 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 3.5 |
14.0 |
GO:2000754 |
regulation of phospholipid scramblase activity(GO:1900161) positive regulation of phospholipid scramblase activity(GO:1900163) regulation of glucosylceramide catabolic process(GO:2000752) positive regulation of glucosylceramide catabolic process(GO:2000753) regulation of sphingomyelin catabolic process(GO:2000754) positive regulation of sphingomyelin catabolic process(GO:2000755) |
| 3.2 |
22.7 |
GO:0090096 |
regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 3.2 |
3.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 3.1 |
15.5 |
GO:1905000 |
regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 3.1 |
15.5 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 3.1 |
6.2 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 3.1 |
6.2 |
GO:1904674 |
positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 2.9 |
8.7 |
GO:0005999 |
xylulose biosynthetic process(GO:0005999) |
| 2.9 |
8.6 |
GO:1902850 |
microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 2.8 |
2.8 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 2.7 |
10.8 |
GO:0006117 |
acetaldehyde metabolic process(GO:0006117) |
| 2.6 |
7.9 |
GO:0060309 |
elastin catabolic process(GO:0060309) |
| 2.5 |
7.6 |
GO:0048320 |
axial mesoderm formation(GO:0048320) |
| 2.5 |
25.1 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 2.5 |
7.5 |
GO:2000547 |
regulation of dendritic cell dendrite assembly(GO:2000547) |
| 2.5 |
9.9 |
GO:0052553 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 2.5 |
7.4 |
GO:0042946 |
glucoside transport(GO:0042946) |
| 2.5 |
9.9 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 2.5 |
2.5 |
GO:0010819 |
regulation of T cell chemotaxis(GO:0010819) positive regulation of T cell chemotaxis(GO:0010820) |
| 2.4 |
9.7 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 2.4 |
12.0 |
GO:0071409 |
cellular response to cycloheximide(GO:0071409) |
| 2.4 |
7.1 |
GO:0090340 |
positive regulation of high-density lipoprotein particle assembly(GO:0090108) positive regulation of secretion of lysosomal enzymes(GO:0090340) |
| 2.3 |
7.0 |
GO:1903461 |
Okazaki fragment processing involved in mitotic DNA replication(GO:1903461) |
| 2.3 |
9.3 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 2.3 |
6.9 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 2.3 |
2.3 |
GO:2001076 |
thorax and anterior abdomen determination(GO:0007356) regulation of metanephric ureteric bud development(GO:2001074) positive regulation of metanephric ureteric bud development(GO:2001076) |
| 2.3 |
11.5 |
GO:0032796 |
uropod organization(GO:0032796) |
| 2.2 |
9.0 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 2.2 |
6.7 |
GO:1990579 |
protein trans-autophosphorylation(GO:0036290) peptidyl-serine trans-autophosphorylation(GO:1990579) |
| 2.2 |
6.5 |
GO:0015734 |
taurine transport(GO:0015734) |
| 2.1 |
4.2 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 2.1 |
6.2 |
GO:1904845 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 2.1 |
10.3 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 2.1 |
10.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 2.0 |
8.2 |
GO:0052362 |
multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 2.0 |
12.2 |
GO:0015862 |
uridine transport(GO:0015862) |
| 2.0 |
2.0 |
GO:0072186 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 2.0 |
6.0 |
GO:0002818 |
intracellular defense response(GO:0002818) |
| 2.0 |
10.0 |
GO:0035740 |
CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 2.0 |
8.0 |
GO:0016333 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 2.0 |
5.9 |
GO:0002380 |
immunoglobulin secretion involved in immune response(GO:0002380) |
| 2.0 |
13.7 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 2.0 |
27.3 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 1.9 |
19.5 |
GO:0038110 |
interleukin-2-mediated signaling pathway(GO:0038110) |
| 1.9 |
7.8 |
GO:0002636 |
positive regulation of germinal center formation(GO:0002636) |
| 1.9 |
7.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 1.9 |
1.9 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 1.9 |
9.5 |
GO:0038156 |
interleukin-3-mediated signaling pathway(GO:0038156) |
| 1.9 |
7.6 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 1.9 |
5.6 |
GO:2000740 |
amniotic stem cell differentiation(GO:0097086) negative regulation of dense core granule biogenesis(GO:2000706) negative regulation of mesenchymal stem cell differentiation(GO:2000740) regulation of amniotic stem cell differentiation(GO:2000797) negative regulation of amniotic stem cell differentiation(GO:2000798) |
| 1.9 |
5.6 |
GO:1903597 |
negative regulation of gap junction assembly(GO:1903597) |
| 1.8 |
7.4 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 1.8 |
9.2 |
GO:0071072 |
negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 1.8 |
9.2 |
GO:2000563 |
positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 1.8 |
7.3 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 1.8 |
8.9 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.8 |
14.2 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 1.8 |
1.8 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 1.8 |
1.8 |
GO:0070383 |
DNA cytosine deamination(GO:0070383) |
| 1.8 |
7.1 |
GO:2000607 |
regulation of cell proliferation involved in mesonephros development(GO:2000606) negative regulation of cell proliferation involved in mesonephros development(GO:2000607) fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000699) glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000701) regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000702) negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation(GO:2000703) regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000733) negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation(GO:2000734) |
| 1.8 |
5.3 |
GO:0009720 |
detection of hormone stimulus(GO:0009720) |
| 1.8 |
3.5 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 1.7 |
29.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.7 |
7.0 |
GO:1903609 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.7 |
3.5 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.7 |
17.2 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 1.7 |
5.2 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 1.7 |
32.4 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 1.7 |
8.5 |
GO:0015766 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 1.7 |
11.8 |
GO:0010266 |
response to vitamin B1(GO:0010266) |
| 1.7 |
6.8 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 1.7 |
5.0 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 1.7 |
6.7 |
GO:0002086 |
diaphragm contraction(GO:0002086) |
| 1.7 |
1.7 |
GO:0033625 |
positive regulation of integrin activation(GO:0033625) |
| 1.7 |
1.7 |
GO:0038112 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 1.7 |
5.0 |
GO:1904604 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 1.6 |
8.2 |
GO:0003068 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 1.6 |
3.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 1.6 |
1.6 |
GO:0034144 |
negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 1.6 |
1.6 |
GO:0033025 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.6 |
4.9 |
GO:2000656 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 1.6 |
8.1 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.6 |
24.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 1.6 |
3.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 1.6 |
7.9 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.6 |
1.6 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 1.6 |
1.6 |
GO:0045588 |
positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 1.6 |
10.9 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.6 |
4.7 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.5 |
4.6 |
GO:0001828 |
inner cell mass cellular morphogenesis(GO:0001828) |
| 1.5 |
7.7 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 1.5 |
3.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 1.5 |
6.1 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.5 |
9.1 |
GO:0035407 |
histone H3-T11 phosphorylation(GO:0035407) |
| 1.5 |
4.5 |
GO:0090222 |
centrosome-templated microtubule nucleation(GO:0090222) |
| 1.5 |
4.5 |
GO:1901535 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.5 |
1.5 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 1.5 |
4.5 |
GO:0009299 |
mRNA transcription(GO:0009299) |
| 1.5 |
4.5 |
GO:1901874 |
negative regulation of post-translational protein modification(GO:1901874) |
| 1.5 |
9.0 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 1.5 |
6.0 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 1.5 |
4.5 |
GO:1902568 |
positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.5 |
8.9 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 1.5 |
4.4 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.5 |
8.9 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 1.5 |
10.3 |
GO:0030421 |
defecation(GO:0030421) |
| 1.5 |
8.8 |
GO:0022614 |
membrane to membrane docking(GO:0022614) |
| 1.5 |
2.9 |
GO:2000196 |
positive regulation of female gonad development(GO:2000196) |
| 1.4 |
5.8 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 1.4 |
5.8 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 1.4 |
1.4 |
GO:1902954 |
regulation of early endosome to recycling endosome transport(GO:1902954) |
| 1.4 |
5.7 |
GO:0036496 |
regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 1.4 |
7.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 1.4 |
5.7 |
GO:1990108 |
protein linear deubiquitination(GO:1990108) |
| 1.4 |
7.1 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.4 |
15.5 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 1.4 |
4.2 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 1.4 |
6.9 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 1.4 |
12.4 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 1.4 |
4.1 |
GO:0030920 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 1.4 |
2.8 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
| 1.4 |
6.9 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.4 |
4.1 |
GO:1904502 |
regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 1.4 |
1.4 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.4 |
1.4 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.4 |
6.8 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 1.4 |
5.4 |
GO:0002881 |
negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.3 |
8.0 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.3 |
4.0 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 1.3 |
2.7 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 1.3 |
4.0 |
GO:0061485 |
memory T cell proliferation(GO:0061485) |
| 1.3 |
1.3 |
GO:0002554 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 1.3 |
3.9 |
GO:0070105 |
positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.3 |
9.2 |
GO:0033152 |
immunoglobulin V(D)J recombination(GO:0033152) |
| 1.3 |
3.9 |
GO:0045062 |
extrathymic T cell selection(GO:0045062) |
| 1.3 |
5.2 |
GO:0044501 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 1.3 |
3.9 |
GO:1903988 |
spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 1.3 |
1.3 |
GO:0042533 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 1.3 |
3.8 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 1.3 |
3.8 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 1.3 |
7.7 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 1.3 |
5.1 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 1.3 |
7.6 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 1.3 |
13.9 |
GO:0006216 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 1.3 |
7.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.3 |
3.8 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 1.3 |
5.0 |
GO:2000435 |
regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 1.2 |
1.2 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 1.2 |
3.7 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 1.2 |
3.7 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 1.2 |
9.8 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 1.2 |
4.9 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 1.2 |
3.6 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 1.2 |
3.6 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 1.2 |
2.4 |
GO:0086098 |
angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 1.2 |
7.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 1.2 |
3.6 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 1.2 |
3.5 |
GO:1990654 |
sebum secreting cell proliferation(GO:1990654) |
| 1.2 |
4.7 |
GO:0032487 |
regulation of Rap protein signal transduction(GO:0032487) |
| 1.2 |
1.2 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 1.2 |
5.9 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 1.2 |
4.7 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 1.2 |
1.2 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.2 |
15.2 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 1.2 |
5.8 |
GO:1904744 |
positive regulation of telomeric DNA binding(GO:1904744) |
| 1.2 |
2.3 |
GO:0030221 |
basophil differentiation(GO:0030221) |
| 1.2 |
5.8 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 1.2 |
6.9 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 1.1 |
8.0 |
GO:1900084 |
regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 1.1 |
6.9 |
GO:0010868 |
negative regulation of triglyceride biosynthetic process(GO:0010868) |
| 1.1 |
12.6 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 1.1 |
3.4 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 1.1 |
3.4 |
GO:0070077 |
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine(GO:0018395) histone arginine demethylation(GO:0070077) histone H3-R2 demethylation(GO:0070078) histone H4-R3 demethylation(GO:0070079) |
| 1.1 |
7.9 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 1.1 |
20.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 1.1 |
1.1 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 1.1 |
13.5 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 1.1 |
2.2 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 1.1 |
1.1 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 1.1 |
12.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 1.1 |
4.4 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 1.1 |
5.5 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 1.1 |
4.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 1.1 |
7.7 |
GO:0071477 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.1 |
1.1 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 1.1 |
2.2 |
GO:2000793 |
cell proliferation involved in heart valve development(GO:2000793) |
| 1.1 |
2.2 |
GO:0044725 |
chromatin reprogramming in the zygote(GO:0044725) |
| 1.1 |
2.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 1.1 |
2.2 |
GO:0090204 |
protein localization to nuclear pore(GO:0090204) |
| 1.1 |
6.4 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 1.1 |
1.1 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 1.1 |
4.3 |
GO:0072287 |
metanephric distal tubule morphogenesis(GO:0072287) |
| 1.1 |
22.4 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 1.1 |
1.1 |
GO:2000399 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 1.1 |
3.2 |
GO:0099553 |
trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
| 1.1 |
25.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 1.1 |
9.5 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 1.1 |
13.7 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.0 |
6.3 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 1.0 |
3.1 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 1.0 |
4.2 |
GO:0002669 |
positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 |
4.2 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 1.0 |
4.2 |
GO:0009447 |
putrescine catabolic process(GO:0009447) |
| 1.0 |
2.1 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 1.0 |
4.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 1.0 |
1.0 |
GO:0060947 |
cardiac vascular smooth muscle cell differentiation(GO:0060947) |
| 1.0 |
1.0 |
GO:0050720 |
interleukin-1 beta biosynthetic process(GO:0050720) |
| 1.0 |
2.1 |
GO:0036369 |
transcription factor catabolic process(GO:0036369) |
| 1.0 |
3.1 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.0 |
1.0 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 1.0 |
12.3 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 1.0 |
7.2 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 1.0 |
4.1 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 1.0 |
3.1 |
GO:0035732 |
nitric oxide storage(GO:0035732) |
| 1.0 |
14.3 |
GO:0043152 |
induction of bacterial agglutination(GO:0043152) |
| 1.0 |
10.2 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.0 |
1.0 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 1.0 |
5.1 |
GO:0034134 |
toll-like receptor 2 signaling pathway(GO:0034134) |
| 1.0 |
7.1 |
GO:0019064 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 1.0 |
3.0 |
GO:1904562 |
phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 1.0 |
5.0 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 1.0 |
4.0 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.0 |
4.0 |
GO:0003383 |
apical constriction(GO:0003383) |
| 1.0 |
4.0 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 1.0 |
2.0 |
GO:2001302 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.0 |
6.0 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 1.0 |
3.0 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 1.0 |
2.0 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 1.0 |
3.0 |
GO:1902811 |
tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.0 |
1.0 |
GO:0003218 |
cardiac left ventricle formation(GO:0003218) |
| 1.0 |
4.9 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 1.0 |
3.0 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 1.0 |
8.8 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.0 |
1.0 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 1.0 |
2.9 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 1.0 |
4.9 |
GO:1901674 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 1.0 |
6.9 |
GO:0002774 |
Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 1.0 |
2.9 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 1.0 |
3.9 |
GO:1902962 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 1.0 |
7.8 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 1.0 |
17.5 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 1.0 |
1.0 |
GO:0072104 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.0 |
2.9 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 1.0 |
8.7 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 1.0 |
1.9 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.0 |
4.8 |
GO:0002357 |
defense response to tumor cell(GO:0002357) |
| 1.0 |
1.0 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 1.0 |
17.4 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 1.0 |
3.9 |
GO:1902724 |
positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.0 |
2.9 |
GO:0010260 |
organ senescence(GO:0010260) |
| 1.0 |
8.6 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 1.0 |
2.9 |
GO:0002316 |
follicular B cell differentiation(GO:0002316) |
| 1.0 |
3.8 |
GO:0051461 |
positive regulation of corticotropin secretion(GO:0051461) |
| 1.0 |
1.9 |
GO:0072535 |
tumor necrosis factor (ligand) superfamily member 11 production(GO:0072535) regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000307) |
| 1.0 |
5.7 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 1.0 |
3.8 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 1.0 |
1.0 |
GO:0035668 |
TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.9 |
2.8 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.9 |
2.8 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.9 |
4.7 |
GO:0072180 |
mesonephric duct morphogenesis(GO:0072180) |
| 0.9 |
7.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.9 |
4.7 |
GO:1902262 |
apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 0.9 |
4.7 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.9 |
2.8 |
GO:0035698 |
CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
| 0.9 |
0.9 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 0.9 |
4.6 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.9 |
12.0 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.9 |
4.6 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.9 |
5.5 |
GO:0034721 |
histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
| 0.9 |
2.8 |
GO:0036166 |
phenotypic switching(GO:0036166) regulation of phenotypic switching by transcription from RNA polymerase II promoter(GO:0100057) regulation of phenotypic switching(GO:1900239) regulation of hydrogen sulfide biosynthetic process(GO:1904826) positive regulation of hydrogen sulfide biosynthetic process(GO:1904828) |
| 0.9 |
1.8 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.9 |
7.4 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.9 |
5.5 |
GO:2000173 |
regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.9 |
4.6 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.9 |
0.9 |
GO:0002859 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.9 |
0.9 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.9 |
5.4 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.9 |
5.4 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.9 |
0.9 |
GO:1900264 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.9 |
1.8 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
| 0.9 |
3.6 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.9 |
3.6 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.9 |
7.2 |
GO:0071802 |
negative regulation of podosome assembly(GO:0071802) |
| 0.9 |
1.8 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.9 |
9.0 |
GO:0030885 |
regulation of myeloid dendritic cell activation(GO:0030885) |
| 0.9 |
2.7 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.9 |
2.7 |
GO:0075732 |
viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 0.9 |
6.2 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.9 |
14.2 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.9 |
0.9 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.9 |
0.9 |
GO:0050653 |
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.9 |
7.0 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.9 |
1.8 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.9 |
12.2 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.9 |
2.6 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.9 |
3.5 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.9 |
0.9 |
GO:0070839 |
divalent metal ion export(GO:0070839) |
| 0.9 |
5.2 |
GO:0090272 |
negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.9 |
0.9 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.9 |
11.3 |
GO:0034349 |
glial cell apoptotic process(GO:0034349) |
| 0.9 |
8.7 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.9 |
2.6 |
GO:0046379 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.9 |
5.2 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.9 |
4.3 |
GO:0045007 |
depurination(GO:0045007) |
| 0.9 |
7.7 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.9 |
5.1 |
GO:0032494 |
response to peptidoglycan(GO:0032494) |
| 0.9 |
3.4 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.9 |
3.4 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.9 |
1.7 |
GO:2001038 |
regulation of cellular response to drug(GO:2001038) |
| 0.9 |
4.3 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.8 |
5.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.8 |
4.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.8 |
2.5 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.8 |
5.9 |
GO:2000814 |
regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.8 |
13.5 |
GO:0060020 |
Bergmann glial cell differentiation(GO:0060020) |
| 0.8 |
8.5 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.8 |
5.1 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.8 |
0.8 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.8 |
1.7 |
GO:1990164 |
histone H2A phosphorylation(GO:1990164) |
| 0.8 |
4.2 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.8 |
2.5 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.8 |
3.3 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.8 |
5.8 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.8 |
1.7 |
GO:1904179 |
regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.8 |
9.2 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.8 |
25.0 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.8 |
5.0 |
GO:0045953 |
negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.8 |
9.2 |
GO:1904627 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.8 |
1.7 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.8 |
14.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.8 |
4.2 |
GO:0060978 |
angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.8 |
2.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.8 |
5.8 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.8 |
0.8 |
GO:0098905 |
regulation of bundle of His cell action potential(GO:0098905) |
| 0.8 |
9.1 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.8 |
0.8 |
GO:0072554 |
blood vessel lumenization(GO:0072554) |
| 0.8 |
1.7 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.8 |
1.7 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
| 0.8 |
4.1 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.8 |
12.4 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.8 |
9.1 |
GO:0044130 |
negative regulation of growth of symbiont in host(GO:0044130) |
| 0.8 |
4.9 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.8 |
4.9 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.8 |
0.8 |
GO:1901985 |
positive regulation of protein acetylation(GO:1901985) |
| 0.8 |
3.3 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 0.8 |
16.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.8 |
0.8 |
GO:1903960 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 0.8 |
3.3 |
GO:1904569 |
regulation of selenocysteine incorporation(GO:1904569) |
| 0.8 |
3.3 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.8 |
9.8 |
GO:0018401 |
peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.8 |
1.6 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.8 |
5.7 |
GO:0019418 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.8 |
2.4 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
| 0.8 |
4.9 |
GO:0070376 |
regulation of ERK5 cascade(GO:0070376) |
| 0.8 |
4.9 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.8 |
2.4 |
GO:0046512 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.8 |
2.4 |
GO:1904719 |
excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.8 |
0.8 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.8 |
20.9 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.8 |
0.8 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.8 |
4.8 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.8 |
7.2 |
GO:0002827 |
positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.8 |
4.0 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.8 |
1.6 |
GO:0034395 |
regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
| 0.8 |
4.0 |
GO:0090402 |
oncogene-induced cell senescence(GO:0090402) |
| 0.8 |
14.3 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.8 |
19.1 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.8 |
3.2 |
GO:0002579 |
positive regulation of antigen processing and presentation(GO:0002579) |
| 0.8 |
4.0 |
GO:0035624 |
receptor transactivation(GO:0035624) |
| 0.8 |
4.0 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.8 |
12.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.8 |
13.4 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.8 |
0.8 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.8 |
2.4 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.8 |
7.8 |
GO:0031087 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.8 |
2.3 |
GO:0048561 |
establishment of organ orientation(GO:0048561) |
| 0.8 |
7.0 |
GO:0014057 |
positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.8 |
3.1 |
GO:0002644 |
negative regulation of tolerance induction(GO:0002644) |
| 0.8 |
7.8 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.8 |
5.4 |
GO:0045408 |
regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.8 |
3.1 |
GO:0070943 |
neutrophil mediated cytotoxicity(GO:0070942) neutrophil mediated killing of symbiont cell(GO:0070943) neutrophil mediated killing of bacterium(GO:0070944) |
| 0.8 |
4.7 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.8 |
10.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.8 |
0.8 |
GO:0060876 |
semicircular canal formation(GO:0060876) |
| 0.8 |
19.4 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.8 |
3.9 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.8 |
3.1 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.8 |
2.3 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.8 |
0.8 |
GO:0061152 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.8 |
0.8 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.8 |
2.3 |
GO:0009644 |
response to high light intensity(GO:0009644) |
| 0.8 |
2.3 |
GO:1904875 |
regulation of DNA ligase activity(GO:1904875) |
| 0.8 |
4.6 |
GO:2001137 |
positive regulation of endocytic recycling(GO:2001137) |
| 0.8 |
2.3 |
GO:0070295 |
renal water absorption(GO:0070295) |
| 0.8 |
21.3 |
GO:0045589 |
regulation of regulatory T cell differentiation(GO:0045589) |
| 0.8 |
0.8 |
GO:1902732 |
positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.8 |
18.3 |
GO:0097296 |
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.8 |
1.5 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.8 |
10.6 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.8 |
2.3 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.8 |
1.5 |
GO:0001768 |
establishment of T cell polarity(GO:0001768) |
| 0.8 |
2.3 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.8 |
1.5 |
GO:0044146 |
negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.7 |
1.5 |
GO:0033004 |
negative regulation of mast cell activation(GO:0033004) |
| 0.7 |
0.7 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.7 |
2.2 |
GO:0060957 |
endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 0.7 |
0.7 |
GO:0060302 |
negative regulation of cytokine activity(GO:0060302) |
| 0.7 |
7.4 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.7 |
2.2 |
GO:0072141 |
renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
| 0.7 |
4.4 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.7 |
0.7 |
GO:0021784 |
postganglionic parasympathetic fiber development(GO:0021784) |
| 0.7 |
0.7 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.7 |
8.1 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.7 |
13.9 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.7 |
5.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 |
9.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.7 |
7.3 |
GO:0006787 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.7 |
112.0 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.7 |
29.0 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.7 |
10.1 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.7 |
1.4 |
GO:0007057 |
spindle assembly involved in female meiosis I(GO:0007057) |
| 0.7 |
2.9 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.7 |
5.0 |
GO:0032417 |
positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.7 |
2.2 |
GO:0036333 |
hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.7 |
1.4 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.7 |
4.3 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.7 |
29.1 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.7 |
2.8 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.7 |
0.7 |
GO:0045076 |
regulation of interleukin-2 biosynthetic process(GO:0045076) |
| 0.7 |
2.1 |
GO:0071626 |
mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
| 0.7 |
0.7 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.7 |
2.8 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.7 |
4.2 |
GO:0000973 |
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.7 |
3.5 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.7 |
11.3 |
GO:0090168 |
Golgi reassembly(GO:0090168) |
| 0.7 |
80.6 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.7 |
2.1 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) |
| 0.7 |
4.9 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.7 |
4.1 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.7 |
3.5 |
GO:0030473 |
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.7 |
5.5 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.7 |
0.7 |
GO:0031125 |
rRNA 3'-end processing(GO:0031125) |
| 0.7 |
5.5 |
GO:0035897 |
proteolysis in other organism(GO:0035897) |
| 0.7 |
2.7 |
GO:0031061 |
negative regulation of histone methylation(GO:0031061) |
| 0.7 |
11.6 |
GO:0002315 |
marginal zone B cell differentiation(GO:0002315) |
| 0.7 |
54.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.7 |
0.7 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 0.7 |
4.8 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.7 |
9.5 |
GO:0060600 |
dichotomous subdivision of an epithelial terminal unit(GO:0060600) |
| 0.7 |
9.5 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.7 |
0.7 |
GO:0038162 |
erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.7 |
1.4 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
| 0.7 |
0.7 |
GO:0048865 |
stem cell fate commitment(GO:0048865) |
| 0.7 |
2.7 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.7 |
2.7 |
GO:0071963 |
establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.7 |
2.7 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.7 |
4.0 |
GO:0046102 |
adenosine catabolic process(GO:0006154) inosine metabolic process(GO:0046102) inosine biosynthetic process(GO:0046103) |
| 0.7 |
2.0 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.7 |
6.0 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.7 |
5.3 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
| 0.7 |
7.3 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.7 |
3.3 |
GO:0046504 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.7 |
4.6 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.7 |
2.6 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.7 |
24.4 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.7 |
19.7 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.7 |
6.6 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.7 |
2.0 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.7 |
20.2 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.7 |
2.0 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.6 |
1.9 |
GO:0036510 |
trimming of terminal mannose on C branch(GO:0036510) |
| 0.6 |
1.3 |
GO:0035261 |
external genitalia morphogenesis(GO:0035261) |
| 0.6 |
1.9 |
GO:0015870 |
acetylcholine transport(GO:0015870) |
| 0.6 |
2.6 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) |
| 0.6 |
0.6 |
GO:0080184 |
response to phenylpropanoid(GO:0080184) |
| 0.6 |
7.0 |
GO:0033151 |
V(D)J recombination(GO:0033151) |
| 0.6 |
2.6 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.6 |
0.6 |
GO:0021747 |
cochlear nucleus development(GO:0021747) |
| 0.6 |
1.3 |
GO:0061739 |
protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.6 |
1.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.6 |
3.2 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.6 |
2.5 |
GO:0071896 |
protein localization to adherens junction(GO:0071896) |
| 0.6 |
2.5 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.6 |
3.8 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.6 |
1.9 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.6 |
10.1 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.6 |
4.4 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.6 |
1.9 |
GO:0048859 |
ganglion mother cell fate determination(GO:0007402) formation of anatomical boundary(GO:0048859) |
| 0.6 |
5.7 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.6 |
1.9 |
GO:0035279 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.6 |
10.7 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.6 |
3.1 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.6 |
6.8 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.6 |
7.4 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.6 |
10.5 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.6 |
14.2 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.6 |
6.2 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.6 |
3.1 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.6 |
1.8 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) |
| 0.6 |
6.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.6 |
1.8 |
GO:0036484 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 0.6 |
0.6 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.6 |
4.3 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.6 |
1.2 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.6 |
2.4 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.6 |
13.3 |
GO:0090022 |
regulation of neutrophil chemotaxis(GO:0090022) |
| 0.6 |
0.6 |
GO:0061443 |
endocardial cushion cell differentiation(GO:0061443) |
| 0.6 |
9.7 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.6 |
2.4 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.6 |
1.8 |
GO:0052405 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.6 |
1.2 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.6 |
9.0 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.6 |
7.2 |
GO:0009912 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.6 |
1.2 |
GO:0043970 |
histone H3-K9 acetylation(GO:0043970) |
| 0.6 |
6.5 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.6 |
3.6 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.6 |
3.0 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.6 |
3.0 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.6 |
1.8 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.6 |
1.2 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.6 |
5.3 |
GO:0043249 |
erythrocyte maturation(GO:0043249) |
| 0.6 |
1.8 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.6 |
2.9 |
GO:0060575 |
intestinal epithelial cell differentiation(GO:0060575) |
| 0.6 |
10.0 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.6 |
1.8 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.6 |
5.3 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.6 |
4.7 |
GO:1903433 |
regulation of constitutive secretory pathway(GO:1903433) |
| 0.6 |
1.8 |
GO:1902824 |
positive regulation of late endosome to lysosome transport(GO:1902824) |
| 0.6 |
1.2 |
GO:0080120 |
CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
| 0.6 |
3.5 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.6 |
2.3 |
GO:2000681 |
negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
| 0.6 |
12.2 |
GO:0002192 |
IRES-dependent translational initiation(GO:0002192) |
| 0.6 |
11.0 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.6 |
0.6 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.6 |
2.3 |
GO:1902287 |
trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.6 |
0.6 |
GO:0036022 |
limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
| 0.6 |
1.1 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.6 |
1.1 |
GO:0045994 |
positive regulation of translational initiation by iron(GO:0045994) |
| 0.6 |
0.6 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.6 |
3.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.6 |
1.1 |
GO:0010663 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.6 |
1.7 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.6 |
1.7 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) |
| 0.6 |
0.6 |
GO:2000193 |
positive regulation of fatty acid transport(GO:2000193) |
| 0.6 |
1.7 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.6 |
1.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.6 |
4.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.6 |
3.9 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.6 |
16.3 |
GO:0032986 |
protein-DNA complex disassembly(GO:0032986) |
| 0.6 |
0.6 |
GO:0055118 |
negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.6 |
2.8 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.6 |
6.2 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.6 |
1.7 |
GO:0002752 |
cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.6 |
2.8 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.6 |
4.4 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.6 |
2.8 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.6 |
2.2 |
GO:0002414 |
immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.6 |
0.6 |
GO:0055096 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.6 |
2.8 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 |
3.9 |
GO:0032966 |
negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.6 |
2.8 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.6 |
0.6 |
GO:1900118 |
negative regulation of execution phase of apoptosis(GO:1900118) |
| 0.6 |
5.5 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.6 |
2.2 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.5 |
8.8 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
1.6 |
GO:0071962 |
mitotic sister chromatid cohesion, centromeric(GO:0071962) |
| 0.5 |
1.1 |
GO:0031498 |
chromatin disassembly(GO:0031498) |
| 0.5 |
3.8 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.5 |
1.6 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.5 |
0.5 |
GO:0006113 |
fermentation(GO:0006113) regulation of fermentation(GO:0043465) |
| 0.5 |
79.2 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.5 |
8.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.5 |
15.1 |
GO:0060396 |
growth hormone receptor signaling pathway(GO:0060396) |
| 0.5 |
13.5 |
GO:0030220 |
platelet formation(GO:0030220) |
| 0.5 |
7.0 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.5 |
1.1 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.5 |
6.4 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.5 |
3.7 |
GO:0030917 |
midbrain-hindbrain boundary development(GO:0030917) |
| 0.5 |
10.1 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.5 |
1.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.5 |
1.1 |
GO:0021610 |
facial nerve development(GO:0021561) facial nerve morphogenesis(GO:0021610) |
| 0.5 |
0.5 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.5 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.5 |
8.5 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.5 |
3.2 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.5 |
1.6 |
GO:0001189 |
RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.5 |
1.6 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.5 |
2.1 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.5 |
2.6 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.5 |
14.2 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.5 |
1.6 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.5 |
2.1 |
GO:0051230 |
mitotic spindle disassembly(GO:0051228) spindle disassembly(GO:0051230) |
| 0.5 |
1.0 |
GO:0031442 |
positive regulation of mRNA 3'-end processing(GO:0031442) |
| 0.5 |
1.0 |
GO:0021558 |
trochlear nerve development(GO:0021558) |
| 0.5 |
5.7 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.5 |
2.1 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.5 |
6.2 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.5 |
3.1 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.5 |
3.1 |
GO:0021775 |
smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
| 0.5 |
1.0 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.5 |
2.1 |
GO:1903936 |
cellular response to sodium arsenite(GO:1903936) |
| 0.5 |
0.5 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.5 |
1.0 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.5 |
6.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.5 |
1.5 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.5 |
2.6 |
GO:0086021 |
SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.5 |
1.5 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.5 |
1.0 |
GO:1901383 |
negative regulation of chorionic trophoblast cell proliferation(GO:1901383) |
| 0.5 |
1.5 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.5 |
0.5 |
GO:0050757 |
thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
| 0.5 |
3.6 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.5 |
6.6 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.5 |
1.5 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.5 |
2.0 |
GO:0035909 |
aorta morphogenesis(GO:0035909) |
| 0.5 |
2.0 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.5 |
0.5 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.5 |
14.1 |
GO:0002260 |
lymphocyte homeostasis(GO:0002260) |
| 0.5 |
92.3 |
GO:0002433 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.5 |
5.0 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.5 |
3.0 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.5 |
3.5 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.5 |
9.0 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.5 |
0.5 |
GO:0043489 |
RNA stabilization(GO:0043489) |
| 0.5 |
2.0 |
GO:0040033 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.5 |
3.5 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.5 |
4.0 |
GO:1903147 |
negative regulation of mitophagy(GO:1903147) |
| 0.5 |
5.0 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.5 |
3.5 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.5 |
9.9 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.5 |
2.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.5 |
29.3 |
GO:0033173 |
calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.5 |
9.9 |
GO:0042340 |
keratan sulfate catabolic process(GO:0042340) |
| 0.5 |
0.5 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.5 |
2.0 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.5 |
2.5 |
GO:0090308 |
regulation of methylation-dependent chromatin silencing(GO:0090308) |
| 0.5 |
2.5 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.5 |
1.0 |
GO:0051987 |
positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
| 0.5 |
2.5 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.5 |
8.4 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.5 |
2.5 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.5 |
0.5 |
GO:0034770 |
histone H4-K20 methylation(GO:0034770) |
| 0.5 |
1.0 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.5 |
1.5 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.5 |
7.3 |
GO:1902894 |
negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.5 |
3.4 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.5 |
1.5 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.5 |
1.9 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.5 |
3.4 |
GO:1903788 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.5 |
1.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 |
7.7 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.5 |
12.0 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.5 |
5.7 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.5 |
0.5 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.5 |
2.4 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.5 |
1.0 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.5 |
1.0 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.5 |
14.7 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.5 |
7.1 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.5 |
1.9 |
GO:0035947 |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
| 0.5 |
0.5 |
GO:1902822 |
regulation of late endosome to lysosome transport(GO:1902822) |
| 0.5 |
1.4 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.5 |
3.3 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.5 |
1.4 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.5 |
2.3 |
GO:0097168 |
transforming growth factor beta activation(GO:0036363) mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.5 |
5.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.5 |
0.9 |
GO:0071332 |
cellular response to fructose stimulus(GO:0071332) |
| 0.5 |
6.5 |
GO:0090235 |
regulation of metaphase plate congression(GO:0090235) |
| 0.5 |
2.3 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.5 |
1.9 |
GO:0002384 |
hepatic immune response(GO:0002384) |
| 0.5 |
2.3 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.5 |
0.5 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.5 |
1.8 |
GO:0061386 |
closure of optic fissure(GO:0061386) |
| 0.5 |
306.8 |
GO:0042119 |
neutrophil activation(GO:0042119) |
| 0.5 |
0.9 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.5 |
8.2 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.5 |
4.1 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.5 |
2.3 |
GO:0060837 |
blood vessel endothelial cell differentiation(GO:0060837) |
| 0.5 |
2.7 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.5 |
2.3 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.5 |
0.5 |
GO:1905165 |
regulation of lysosomal protein catabolic process(GO:1905165) |
| 0.5 |
0.9 |
GO:1900190 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.5 |
1.8 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
0.5 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.5 |
13.5 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.5 |
1.8 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 |
4.5 |
GO:0060033 |
anatomical structure regression(GO:0060033) |
| 0.4 |
3.1 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.4 |
1.8 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 0.4 |
4.9 |
GO:1904327 |
protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.4 |
5.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.4 |
1.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.4 |
0.9 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.4 |
5.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.4 |
5.8 |
GO:0001773 |
myeloid dendritic cell activation(GO:0001773) |
| 0.4 |
0.9 |
GO:1900020 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.4 |
5.8 |
GO:2001032 |
regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.4 |
1.3 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.4 |
1.8 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.4 |
1.8 |
GO:1905045 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.4 |
1.3 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.4 |
0.4 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.4 |
2.2 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.4 |
3.9 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.4 |
4.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.4 |
3.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.4 |
0.9 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.4 |
0.4 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.4 |
12.0 |
GO:0071526 |
semaphorin-plexin signaling pathway(GO:0071526) |
| 0.4 |
1.3 |
GO:0043137 |
DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
| 0.4 |
2.6 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.4 |
3.8 |
GO:1902572 |
negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.4 |
4.3 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.4 |
2.6 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.4 |
1.7 |
GO:0060872 |
semicircular canal development(GO:0060872) |
| 0.4 |
0.4 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.4 |
1.7 |
GO:0042776 |
mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.4 |
3.4 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.4 |
4.6 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 |
1.3 |
GO:0060178 |
regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.4 |
5.1 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.4 |
4.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.4 |
2.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.4 |
2.9 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.4 |
0.4 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.4 |
5.0 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.4 |
1.2 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.4 |
1.7 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.4 |
10.4 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.4 |
2.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.4 |
3.7 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.4 |
2.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) |
| 0.4 |
1.7 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.4 |
2.9 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.4 |
5.0 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.4 |
0.8 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.4 |
0.8 |
GO:0007518 |
myoblast fate determination(GO:0007518) |
| 0.4 |
2.5 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.4 |
1.2 |
GO:0051873 |
disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.4 |
0.4 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.4 |
3.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.4 |
3.7 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.4 |
4.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.4 |
2.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.4 |
0.8 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.4 |
1.2 |
GO:1990258 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.4 |
4.1 |
GO:0007549 |
dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.4 |
9.3 |
GO:2000188 |
regulation of cholesterol homeostasis(GO:2000188) |
| 0.4 |
1.2 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.4 |
10.8 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.4 |
6.7 |
GO:0046782 |
regulation of viral transcription(GO:0046782) |
| 0.4 |
3.2 |
GO:0060372 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.4 |
23.4 |
GO:0007077 |
mitotic nuclear envelope disassembly(GO:0007077) |
| 0.4 |
3.9 |
GO:1902101 |
positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.4 |
1.2 |
GO:0001992 |
regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 |
6.3 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.4 |
1.6 |
GO:0032202 |
telomere assembly(GO:0032202) |
| 0.4 |
1.6 |
GO:0038031 |
non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 |
0.8 |
GO:0048205 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.4 |
4.7 |
GO:0090656 |
t-circle formation(GO:0090656) |
| 0.4 |
0.4 |
GO:0072708 |
response to sorbitol(GO:0072708) |
| 0.4 |
14.7 |
GO:1904837 |
beta-catenin-TCF complex assembly(GO:1904837) |
| 0.4 |
3.9 |
GO:0006298 |
mismatch repair(GO:0006298) |
| 0.4 |
5.8 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.4 |
0.4 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.4 |
0.4 |
GO:0045061 |
thymic T cell selection(GO:0045061) |
| 0.4 |
4.6 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.4 |
6.5 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.4 |
9.5 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.4 |
5.7 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.4 |
1.9 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.4 |
0.8 |
GO:2000360 |
negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.4 |
2.3 |
GO:0032910 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
| 0.4 |
1.9 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 |
0.4 |
GO:0060585 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.4 |
9.1 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.4 |
3.0 |
GO:0032201 |
telomere maintenance via semi-conservative replication(GO:0032201) |
| 0.4 |
0.4 |
GO:0035963 |
cellular response to interleukin-13(GO:0035963) |
| 0.4 |
3.0 |
GO:0060988 |
lipid tube assembly(GO:0060988) |
| 0.4 |
4.1 |
GO:0043555 |
regulation of translation in response to stress(GO:0043555) |
| 0.4 |
1.5 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.4 |
0.4 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.4 |
1.1 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.4 |
7.1 |
GO:0030210 |
heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.4 |
3.3 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.4 |
1.9 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.4 |
1.5 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.4 |
0.7 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.4 |
0.7 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.4 |
1.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.4 |
1.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
7.7 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.4 |
0.7 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.4 |
1.1 |
GO:2000320 |
negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.4 |
1.1 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.4 |
2.9 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.4 |
18.4 |
GO:0031294 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.4 |
2.9 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.4 |
2.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.4 |
1.8 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.4 |
2.9 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.4 |
1.4 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.4 |
0.7 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.4 |
3.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.4 |
3.6 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.4 |
1.1 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
2.5 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.4 |
0.7 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.4 |
9.6 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.4 |
6.0 |
GO:0045636 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.4 |
1.4 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.4 |
2.5 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.4 |
12.4 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.4 |
1.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.4 |
0.7 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.4 |
1.1 |
GO:1904528 |
positive regulation of microtubule binding(GO:1904528) |
| 0.4 |
0.7 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.3 |
2.4 |
GO:0019883 |
antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.3 |
0.7 |
GO:0036491 |
regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
| 0.3 |
8.0 |
GO:0043097 |
pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
| 0.3 |
3.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.3 |
2.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.3 |
8.4 |
GO:0036150 |
phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.3 |
9.7 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.3 |
1.0 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.3 |
1.0 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.3 |
2.1 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.3 |
9.7 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.3 |
2.1 |
GO:0042713 |
sperm ejaculation(GO:0042713) |
| 0.3 |
1.4 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.3 |
8.6 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.3 |
3.1 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.3 |
1.0 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.3 |
1.0 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.3 |
1.7 |
GO:0035087 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.3 |
1.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.3 |
5.8 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.3 |
0.7 |
GO:0048368 |
lateral mesoderm development(GO:0048368) |
| 0.3 |
5.1 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.3 |
3.0 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.3 |
0.3 |
GO:2000834 |
androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.3 |
1.0 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 |
6.7 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.3 |
6.7 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.3 |
1.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.3 |
1.3 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.3 |
0.3 |
GO:0021897 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.3 |
0.3 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 |
6.3 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.3 |
1.7 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
2.3 |
GO:0010912 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.3 |
0.7 |
GO:1900274 |
regulation of phospholipase C activity(GO:1900274) |
| 0.3 |
1.3 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 0.3 |
0.7 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 |
3.0 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.3 |
2.0 |
GO:0097384 |
cellular lipid biosynthetic process(GO:0097384) |
| 0.3 |
15.5 |
GO:0032481 |
positive regulation of type I interferon production(GO:0032481) |
| 0.3 |
2.3 |
GO:2000774 |
positive regulation of cellular senescence(GO:2000774) |
| 0.3 |
0.7 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.3 |
3.9 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.3 |
2.3 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.3 |
3.6 |
GO:0035385 |
Roundabout signaling pathway(GO:0035385) |
| 0.3 |
36.4 |
GO:0002377 |
immunoglobulin production(GO:0002377) |
| 0.3 |
0.3 |
GO:0070316 |
regulation of G0 to G1 transition(GO:0070316) |
| 0.3 |
0.6 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.3 |
1.0 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.3 |
2.6 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.3 |
2.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.3 |
0.3 |
GO:0035977 |
protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
| 0.3 |
1.0 |
GO:0006463 |
steroid hormone receptor complex assembly(GO:0006463) |
| 0.3 |
0.3 |
GO:0060850 |
regulation of transcription involved in cell fate commitment(GO:0060850) |
| 0.3 |
0.3 |
GO:0046833 |
positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 |
3.5 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.3 |
1.0 |
GO:0046049 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 |
10.2 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.3 |
1.6 |
GO:0035630 |
bone mineralization involved in bone maturation(GO:0035630) |
| 0.3 |
3.2 |
GO:0046852 |
positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.3 |
1.6 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
| 0.3 |
3.8 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.3 |
1.6 |
GO:0000722 |
telomere maintenance via recombination(GO:0000722) |
| 0.3 |
1.9 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.3 |
7.0 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.3 |
0.9 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.3 |
6.9 |
GO:0006998 |
nuclear envelope organization(GO:0006998) |
| 0.3 |
2.2 |
GO:0070254 |
mucus secretion(GO:0070254) |
| 0.3 |
2.2 |
GO:0003085 |
negative regulation of systemic arterial blood pressure(GO:0003085) |
| 0.3 |
2.2 |
GO:0000466 |
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
| 0.3 |
4.0 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.3 |
7.1 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.3 |
5.3 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.3 |
1.2 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.3 |
7.7 |
GO:0035666 |
TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
| 0.3 |
2.2 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.3 |
1.2 |
GO:0071315 |
cellular response to morphine(GO:0071315) cellular response to isoquinoline alkaloid(GO:0071317) |
| 0.3 |
7.7 |
GO:1901224 |
positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.3 |
0.9 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.3 |
2.8 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
0.3 |
GO:1904116 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.3 |
1.8 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.3 |
2.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.3 |
19.3 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.3 |
0.3 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
1.2 |
GO:1904219 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.3 |
6.7 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.3 |
7.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 |
0.6 |
GO:0031990 |
mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.3 |
0.3 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.3 |
0.9 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.3 |
2.1 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.3 |
3.3 |
GO:0070231 |
T cell apoptotic process(GO:0070231) |
| 0.3 |
1.2 |
GO:0002295 |
T-helper cell lineage commitment(GO:0002295) CD4-positive, alpha-beta T cell lineage commitment(GO:0043373) |
| 0.3 |
5.7 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 |
0.6 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.3 |
1.2 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.3 |
1.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.3 |
3.0 |
GO:0002183 |
cytoplasmic translational initiation(GO:0002183) |
| 0.3 |
3.5 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.3 |
0.3 |
GO:0021650 |
vestibulocochlear nerve formation(GO:0021650) |
| 0.3 |
0.9 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.3 |
2.3 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.3 |
9.3 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.3 |
4.9 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.3 |
0.9 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.3 |
0.3 |
GO:0002407 |
dendritic cell chemotaxis(GO:0002407) |
| 0.3 |
8.4 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.3 |
1.2 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.3 |
7.2 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.3 |
0.3 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.3 |
14.4 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.3 |
1.1 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.3 |
28.7 |
GO:0042795 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.3 |
2.9 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.3 |
1.4 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.3 |
0.9 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.3 |
0.6 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.3 |
0.3 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.3 |
0.6 |
GO:0007079 |
mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.3 |
0.8 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.3 |
1.4 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.3 |
2.5 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
1.7 |
GO:1901355 |
cellular response to rapamycin(GO:0072752) response to rapamycin(GO:1901355) |
| 0.3 |
1.7 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.3 |
1.1 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.3 |
9.7 |
GO:1904659 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 |
0.8 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.3 |
0.8 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.3 |
2.2 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.3 |
0.8 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.3 |
0.3 |
GO:0036005 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.3 |
9.3 |
GO:0042771 |
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.3 |
1.6 |
GO:0050668 |
cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
| 0.3 |
2.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.3 |
1.6 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
0.8 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 |
2.4 |
GO:0035583 |
sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.3 |
3.2 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.3 |
1.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.3 |
0.5 |
GO:0031126 |
snoRNA 3'-end processing(GO:0031126) |
| 0.3 |
0.8 |
GO:0035048 |
splicing factor protein import into nucleus(GO:0035048) |
| 0.3 |
26.1 |
GO:0071277 |
cellular response to calcium ion(GO:0071277) |
| 0.3 |
1.1 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.3 |
1.1 |
GO:0033327 |
Leydig cell differentiation(GO:0033327) |
| 0.3 |
6.6 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) |
| 0.3 |
3.4 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.3 |
0.8 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.3 |
8.2 |
GO:0048146 |
positive regulation of fibroblast proliferation(GO:0048146) |
| 0.3 |
0.8 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.3 |
12.1 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.3 |
0.5 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.3 |
1.6 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.3 |
0.3 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.3 |
1.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.3 |
4.2 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.3 |
1.8 |
GO:1901096 |
regulation of autophagosome maturation(GO:1901096) |
| 0.3 |
1.8 |
GO:0031054 |
pre-miRNA processing(GO:0031054) |
| 0.3 |
0.8 |
GO:0036245 |
cellular response to menadione(GO:0036245) |
| 0.3 |
1.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.3 |
0.5 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.3 |
0.5 |
GO:1903862 |
positive regulation of oxidative phosphorylation(GO:1903862) |
| 0.3 |
1.0 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.3 |
0.8 |
GO:0036302 |
atrioventricular canal development(GO:0036302) |
| 0.3 |
0.8 |
GO:0035638 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.3 |
1.5 |
GO:2000984 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.3 |
0.3 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.3 |
0.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.3 |
0.8 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.3 |
4.3 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.3 |
1.8 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
0.8 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.3 |
2.8 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.3 |
1.0 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.3 |
0.3 |
GO:0003176 |
aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
| 0.2 |
3.0 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.2 |
1.5 |
GO:0002084 |
protein depalmitoylation(GO:0002084) |
| 0.2 |
2.7 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.2 |
0.2 |
GO:1904782 |
negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 0.2 |
0.2 |
GO:0021937 |
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.2 |
1.7 |
GO:0000018 |
regulation of DNA recombination(GO:0000018) |
| 0.2 |
0.7 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
1.2 |
GO:0009098 |
branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.2 |
1.5 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
2.7 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
1.0 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
2.9 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.2 |
0.2 |
GO:0014916 |
regulation of lung blood pressure(GO:0014916) |
| 0.2 |
1.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
0.2 |
GO:0071352 |
cellular response to interleukin-2(GO:0071352) |
| 0.2 |
0.5 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.2 |
0.7 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.2 |
1.2 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.2 |
5.8 |
GO:0006303 |
double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.2 |
1.0 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 0.2 |
0.2 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.2 |
18.3 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.2 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.2 |
0.7 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.2 |
4.2 |
GO:0010634 |
positive regulation of epithelial cell migration(GO:0010634) |
| 0.2 |
0.2 |
GO:0018963 |
phthalate metabolic process(GO:0018963) |
| 0.2 |
0.5 |
GO:0070561 |
vitamin D catabolic process(GO:0042369) vitamin D receptor signaling pathway(GO:0070561) |
| 0.2 |
0.2 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.2 |
9.6 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.2 |
1.6 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.2 |
1.9 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.2 |
0.5 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.2 |
1.2 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.2 |
1.6 |
GO:0034968 |
histone lysine methylation(GO:0034968) |
| 0.2 |
6.9 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.2 |
1.8 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
0.2 |
GO:0060770 |
negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.2 |
3.4 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.2 |
6.9 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
2.7 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.2 |
0.7 |
GO:0090131 |
mesenchyme migration(GO:0090131) |
| 0.2 |
2.7 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.2 |
1.1 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 0.2 |
0.2 |
GO:1901994 |
negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 0.2 |
2.3 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.2 |
7.5 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.2 |
0.7 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.2 |
6.3 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.2 |
0.5 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
1.1 |
GO:0070602 |
regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 |
1.6 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.2 |
1.8 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.2 |
0.2 |
GO:0060966 |
regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
| 0.2 |
2.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 |
0.7 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 |
0.9 |
GO:0044837 |
assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 |
17.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.2 |
22.2 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.2 |
0.4 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
0.2 |
GO:0000349 |
generation of catalytic spliceosome for first transesterification step(GO:0000349) |
| 0.2 |
0.9 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.2 |
2.2 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
1.1 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
0.9 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.2 |
0.4 |
GO:1904816 |
regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.2 |
0.7 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
1.5 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
2.0 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.2 |
9.1 |
GO:0050851 |
antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.2 |
2.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.2 |
0.6 |
GO:0051389 |
inactivation of MAPKK activity(GO:0051389) |
| 0.2 |
0.6 |
GO:0018201 |
peptidyl-glycine modification(GO:0018201) |
| 0.2 |
0.6 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 |
9.9 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.2 |
3.7 |
GO:1901532 |
regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
| 0.2 |
4.1 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.2 |
0.9 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.2 |
6.9 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.2 |
5.8 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.2 |
0.4 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.2 |
1.1 |
GO:0060252 |
positive regulation of glial cell proliferation(GO:0060252) |
| 0.2 |
1.1 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
0.6 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.2 |
5.0 |
GO:0042994 |
cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.2 |
4.8 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.2 |
0.6 |
GO:0044111 |
development involved in symbiotic interaction(GO:0044111) |
| 0.2 |
1.5 |
GO:2001171 |
positive regulation of ATP biosynthetic process(GO:2001171) |
| 0.2 |
0.2 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.2 |
2.5 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 |
0.6 |
GO:0002291 |
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.2 |
0.4 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.2 |
1.0 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
9.8 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.2 |
1.6 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.2 |
1.0 |
GO:1902659 |
regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 |
2.8 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.2 |
0.6 |
GO:0097011 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.2 |
5.0 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.2 |
3.6 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.2 |
1.2 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.2 |
0.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
4.6 |
GO:0030098 |
lymphocyte differentiation(GO:0030098) |
| 0.2 |
0.4 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.2 |
0.8 |
GO:0048538 |
thymus development(GO:0048538) |
| 0.2 |
0.6 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.2 |
1.4 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 |
1.0 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.2 |
2.7 |
GO:0031640 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.2 |
2.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.2 |
1.4 |
GO:0045141 |
meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.2 |
1.2 |
GO:0033387 |
putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.2 |
0.6 |
GO:0060827 |
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 0.2 |
0.2 |
GO:0035378 |
carbon dioxide transmembrane transport(GO:0035378) |
| 0.2 |
0.6 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 |
0.2 |
GO:0031342 |
negative regulation of cell killing(GO:0031342) |
| 0.2 |
2.9 |
GO:0010830 |
regulation of myotube differentiation(GO:0010830) |
| 0.2 |
1.9 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
0.6 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.2 |
0.6 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.2 |
4.7 |
GO:0097576 |
vacuole fusion(GO:0097576) |
| 0.2 |
2.1 |
GO:0060148 |
positive regulation of posttranscriptional gene silencing(GO:0060148) |
| 0.2 |
3.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.2 |
0.6 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
20.4 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.2 |
1.3 |
GO:0032264 |
IMP salvage(GO:0032264) |
| 0.2 |
1.7 |
GO:0032465 |
regulation of cytokinesis(GO:0032465) |
| 0.2 |
1.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.2 |
6.8 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.2 |
1.5 |
GO:0071798 |
response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.2 |
2.2 |
GO:0043485 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.2 |
1.1 |
GO:0010166 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.2 |
0.5 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.2 |
6.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.2 |
0.4 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.2 |
6.1 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.2 |
1.3 |
GO:0045835 |
negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 |
6.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.2 |
1.6 |
GO:0015811 |
L-cystine transport(GO:0015811) |
| 0.2 |
0.9 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.2 |
0.5 |
GO:2000078 |
type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.2 |
0.2 |
GO:1902218 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 0.2 |
1.2 |
GO:0048333 |
mesodermal cell differentiation(GO:0048333) |
| 0.2 |
0.4 |
GO:0034140 |
negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.2 |
6.9 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.2 |
0.4 |
GO:0060434 |
bronchus morphogenesis(GO:0060434) |
| 0.2 |
0.9 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
1.2 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.2 |
0.5 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
3.8 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.2 |
0.3 |
GO:0002544 |
chronic inflammatory response(GO:0002544) |
| 0.2 |
1.0 |
GO:0071425 |
hematopoietic stem cell proliferation(GO:0071425) |
| 0.2 |
0.2 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.2 |
1.7 |
GO:0002943 |
tRNA dihydrouridine synthesis(GO:0002943) |
| 0.2 |
7.3 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
0.3 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
1.4 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.2 |
1.2 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.2 |
2.8 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.2 |
0.5 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 0.2 |
4.8 |
GO:0070664 |
negative regulation of leukocyte proliferation(GO:0070664) |
| 0.2 |
0.5 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.2 |
1.2 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
0.3 |
GO:1901800 |
positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 |
0.3 |
GO:1903436 |
regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.2 |
2.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
10.4 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.2 |
1.5 |
GO:0034465 |
response to carbon monoxide(GO:0034465) |
| 0.2 |
0.3 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
| 0.2 |
1.0 |
GO:0060638 |
mesenchymal-epithelial cell signaling(GO:0060638) |
| 0.2 |
1.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
1.1 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.2 |
0.3 |
GO:0009213 |
pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.2 |
8.5 |
GO:0002223 |
stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.2 |
1.7 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.2 |
2.3 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.2 |
0.9 |
GO:0006127 |
glycerophosphate shuttle(GO:0006127) |
| 0.2 |
1.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.6 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.2 |
0.3 |
GO:0051546 |
keratinocyte migration(GO:0051546) |
| 0.2 |
0.2 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
1.5 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.2 |
2.3 |
GO:0034505 |
tooth mineralization(GO:0034505) |
| 0.2 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
0.8 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.2 |
1.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
0.2 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.2 |
0.8 |
GO:0035585 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.2 |
0.6 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
| 0.2 |
0.5 |
GO:0042088 |
T-helper 1 type immune response(GO:0042088) |
| 0.2 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.2 |
2.1 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.1 |
1.5 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.1 |
3.6 |
GO:0016573 |
histone acetylation(GO:0016573) |
| 0.1 |
4.2 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
1.0 |
GO:0001542 |
ovulation from ovarian follicle(GO:0001542) |
| 0.1 |
2.1 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.1 |
0.1 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.1 |
0.4 |
GO:1905146 |
lysosomal protein catabolic process(GO:1905146) |
| 0.1 |
4.0 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.4 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.1 |
1.6 |
GO:0070828 |
heterochromatin organization(GO:0070828) |
| 0.1 |
6.5 |
GO:0035722 |
interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 0.1 |
2.1 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.1 |
2.6 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 |
0.6 |
GO:0060087 |
relaxation of vascular smooth muscle(GO:0060087) |
| 0.1 |
0.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
4.4 |
GO:0071427 |
mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.1 |
0.1 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.1 |
1.2 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.1 |
5.7 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.1 |
5.2 |
GO:0045071 |
negative regulation of viral genome replication(GO:0045071) |
| 0.1 |
0.4 |
GO:2000647 |
negative regulation of stem cell proliferation(GO:2000647) |
| 0.1 |
1.2 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
1.6 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.1 |
1.0 |
GO:0001945 |
lymph vessel development(GO:0001945) |
| 0.1 |
0.3 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 |
0.4 |
GO:1903318 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.1 |
0.6 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
10.3 |
GO:0002244 |
hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.1 |
0.6 |
GO:1902941 |
transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
| 0.1 |
0.7 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.3 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
3.6 |
GO:0045737 |
positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 0.1 |
0.4 |
GO:0002001 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) |
| 0.1 |
3.9 |
GO:0050690 |
regulation of defense response to virus by virus(GO:0050690) |
| 0.1 |
3.2 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.1 |
0.5 |
GO:0032675 |
regulation of interleukin-6 production(GO:0032675) |
| 0.1 |
0.4 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.1 |
0.4 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
1.6 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.8 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.1 |
0.4 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.5 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
0.1 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
18.6 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
1.8 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.1 |
0.1 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.1 |
6.2 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
1.2 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.1 |
0.3 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.1 |
0.8 |
GO:0002686 |
negative regulation of leukocyte migration(GO:0002686) |
| 0.1 |
0.4 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.4 |
GO:0030719 |
oocyte construction(GO:0007308) oocyte axis specification(GO:0007309) oocyte anterior/posterior axis specification(GO:0007314) pole plasm assembly(GO:0007315) maternal determination of anterior/posterior axis, embryo(GO:0008358) P granule organization(GO:0030719) |
| 0.1 |
0.8 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.1 |
0.3 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
1.2 |
GO:0051439 |
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 0.1 |
1.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
0.8 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.1 |
GO:0007442 |
hindgut morphogenesis(GO:0007442) |
| 0.1 |
3.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.9 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
1.8 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 |
0.3 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
1.0 |
GO:0000732 |
strand displacement(GO:0000732) |
| 0.1 |
0.1 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.5 |
GO:0002158 |
osteoclast proliferation(GO:0002158) |
| 0.1 |
1.9 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.9 |
GO:1903020 |
positive regulation of glycoprotein metabolic process(GO:1903020) |
| 0.1 |
5.3 |
GO:0050727 |
regulation of inflammatory response(GO:0050727) |
| 0.1 |
0.1 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.1 |
0.7 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
0.7 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.6 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
1.3 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
1.1 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 |
0.2 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.1 |
GO:0015864 |
pyrimidine nucleoside transport(GO:0015864) |
| 0.1 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.8 |
GO:0043586 |
tongue development(GO:0043586) |
| 0.1 |
1.2 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.1 |
0.5 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.1 |
1.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.4 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.1 |
0.1 |
GO:0060467 |
negative regulation of fertilization(GO:0060467) |
| 0.1 |
25.0 |
GO:0001525 |
angiogenesis(GO:0001525) |
| 0.1 |
0.7 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.1 |
0.8 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.1 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.1 |
13.8 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.1 |
0.8 |
GO:0050686 |
negative regulation of mRNA processing(GO:0050686) |
| 0.1 |
0.7 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
0.7 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
8.4 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.1 |
0.9 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
1.5 |
GO:1903321 |
negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
| 0.1 |
1.6 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.1 |
0.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
2.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
2.0 |
GO:0030888 |
regulation of B cell proliferation(GO:0030888) |
| 0.1 |
0.3 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.5 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
1.3 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.1 |
0.1 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.6 |
GO:0001502 |
cartilage condensation(GO:0001502) |
| 0.1 |
0.6 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.1 |
1.5 |
GO:0071174 |
mitotic spindle checkpoint(GO:0071174) |
| 0.1 |
0.3 |
GO:0021984 |
adenohypophysis development(GO:0021984) |
| 0.1 |
0.7 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.1 |
6.7 |
GO:0031929 |
TOR signaling(GO:0031929) |
| 0.1 |
3.6 |
GO:0034724 |
DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 |
0.1 |
GO:0001711 |
endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) |
| 0.1 |
1.9 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.1 |
3.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.7 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.1 |
0.3 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 |
0.4 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.1 |
1.0 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.1 |
0.3 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.1 |
0.5 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.1 |
0.6 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.7 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
5.5 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.4 |
GO:0050712 |
negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 |
0.3 |
GO:0045651 |
positive regulation of macrophage differentiation(GO:0045651) |
| 0.1 |
0.8 |
GO:0048635 |
negative regulation of muscle organ development(GO:0048635) |
| 0.1 |
0.4 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 |
0.2 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 |
0.3 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
1.0 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.1 |
0.8 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.5 |
GO:2001300 |
lipoxin metabolic process(GO:2001300) |
| 0.1 |
2.2 |
GO:0006368 |
transcription elongation from RNA polymerase II promoter(GO:0006368) |
| 0.1 |
0.2 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.4 |
GO:1904872 |
regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 0.1 |
1.0 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.1 |
0.4 |
GO:0010755 |
regulation of plasminogen activation(GO:0010755) |
| 0.1 |
0.5 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.1 |
0.6 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.5 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.1 |
0.1 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.1 |
1.1 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 0.1 |
0.3 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.8 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 |
1.4 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
0.1 |
GO:0000354 |
cis assembly of pre-catalytic spliceosome(GO:0000354) |
| 0.1 |
0.4 |
GO:0036233 |
glycine import(GO:0036233) |
| 0.1 |
0.1 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.1 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
0.6 |
GO:0001570 |
vasculogenesis(GO:0001570) |
| 0.1 |
1.1 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
0.4 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
0.3 |
GO:0035853 |
chromosome passenger complex localization to spindle midzone(GO:0035853) |
| 0.1 |
0.8 |
GO:0002475 |
antigen processing and presentation via MHC class Ib(GO:0002475) |
| 0.1 |
1.5 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.1 |
0.3 |
GO:0033306 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.1 |
0.3 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.1 |
GO:0072711 |
response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
| 0.1 |
2.3 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.1 |
0.3 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.1 |
2.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.6 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
1.7 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.1 |
0.3 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.1 |
1.6 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
0.9 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.1 |
0.2 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
0.4 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.1 |
0.5 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.1 |
0.5 |
GO:0010458 |
exit from mitosis(GO:0010458) |
| 0.1 |
0.9 |
GO:0032088 |
negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
| 0.1 |
0.1 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.1 |
0.2 |
GO:0033078 |
extrathymic T cell differentiation(GO:0033078) regulation of extrathymic T cell differentiation(GO:0033082) |
| 0.1 |
1.6 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.1 |
0.2 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.3 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.1 |
2.5 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.1 |
2.8 |
GO:1903322 |
positive regulation of protein modification by small protein conjugation or removal(GO:1903322) |
| 0.1 |
0.3 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
2.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.2 |
GO:1902573 |
positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.1 |
0.6 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.1 |
0.3 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 |
0.2 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.1 |
45.1 |
GO:0000122 |
negative regulation of transcription from RNA polymerase II promoter(GO:0000122) |
| 0.1 |
0.1 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
0.4 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.1 |
0.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
2.3 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
0.1 |
GO:0032258 |
CVT pathway(GO:0032258) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
1.1 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.1 |
3.0 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
1.3 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.4 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
1.5 |
GO:0006305 |
DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
| 0.1 |
1.6 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.1 |
0.4 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
0.4 |
GO:0002429 |
immune response-activating cell surface receptor signaling pathway(GO:0002429) |
| 0.1 |
1.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.1 |
GO:0006295 |
nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 0.1 |
0.6 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.1 |
GO:0032604 |
granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.1 |
0.4 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
2.3 |
GO:0031497 |
chromatin assembly(GO:0031497) |
| 0.1 |
0.1 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
4.2 |
GO:0030049 |
muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.1 |
1.8 |
GO:0043122 |
regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043122) |
| 0.1 |
0.8 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.1 |
0.2 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.1 |
0.1 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.1 |
0.1 |
GO:0032205 |
negative regulation of telomere maintenance(GO:0032205) |
| 0.1 |
0.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.6 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.1 |
0.3 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.5 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.4 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 |
0.1 |
GO:1903337 |
positive regulation of vacuolar transport(GO:1903337) |
| 0.1 |
2.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.1 |
GO:0036093 |
male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 |
0.2 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.5 |
GO:0035965 |
cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.1 |
1.8 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.1 |
2.1 |
GO:0050818 |
regulation of coagulation(GO:0050818) |
| 0.1 |
10.5 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.1 |
0.1 |
GO:0034695 |
response to prostaglandin E(GO:0034695) |
| 0.0 |
1.4 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.2 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.0 |
0.1 |
GO:0034197 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.0 |
1.1 |
GO:0003298 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.5 |
GO:0010972 |
negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 |
0.6 |
GO:0007143 |
female meiotic division(GO:0007143) |
| 0.0 |
5.3 |
GO:0016579 |
protein deubiquitination(GO:0016579) |
| 0.0 |
0.2 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.0 |
0.2 |
GO:0010870 |
positive regulation of receptor biosynthetic process(GO:0010870) |
| 0.0 |
0.0 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.0 |
1.2 |
GO:0015695 |
organic cation transport(GO:0015695) |
| 0.0 |
0.1 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.1 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.5 |
GO:0030262 |
apoptotic nuclear changes(GO:0030262) |
| 0.0 |
0.7 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.2 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.1 |
GO:0002769 |
natural killer cell inhibitory signaling pathway(GO:0002769) |
| 0.0 |
0.0 |
GO:1904933 |
regulation of cell proliferation in midbrain(GO:1904933) |
| 0.0 |
0.3 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.4 |
GO:0075733 |
intracellular transport of virus(GO:0075733) |
| 0.0 |
0.1 |
GO:0046532 |
regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 |
0.3 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.0 |
0.4 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.0 |
0.0 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
1.3 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
| 0.0 |
0.5 |
GO:0071875 |
adrenergic receptor signaling pathway(GO:0071875) |
| 0.0 |
0.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
2.5 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.1 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.0 |
0.6 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.3 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.0 |
1.0 |
GO:0000075 |
cell cycle checkpoint(GO:0000075) |
| 0.0 |
0.1 |
GO:0038042 |
dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.0 |
0.6 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.2 |
GO:0009253 |
peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 |
0.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0051083 |
'de novo' cotranslational protein folding(GO:0051083) |
| 0.0 |
0.0 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.0 |
0.6 |
GO:0090280 |
positive regulation of calcium ion import(GO:0090280) |
| 0.0 |
0.1 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.0 |
0.1 |
GO:0046322 |
negative regulation of fatty acid oxidation(GO:0046322) |
| 0.0 |
0.4 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.5 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.1 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.0 |
0.7 |
GO:0002757 |
immune response-activating signal transduction(GO:0002757) |
| 0.0 |
0.1 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.1 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.0 |
0.0 |
GO:0051771 |
negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
| 0.0 |
0.4 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.0 |
0.1 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.0 |
0.3 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.1 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.2 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.0 |
0.1 |
GO:0045815 |
positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.0 |
0.0 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.0 |
0.0 |
GO:0009886 |
post-embryonic morphogenesis(GO:0009886) |
| 0.0 |
0.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.0 |
GO:0032714 |
negative regulation of interleukin-5 production(GO:0032714) |
| 0.0 |
0.1 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.0 |
0.1 |
GO:2000543 |
positive regulation of gastrulation(GO:2000543) |
| 0.0 |
0.0 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.0 |
0.0 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.0 |
0.1 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.0 |
0.1 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.0 |
0.1 |
GO:0036295 |
cellular response to increased oxygen levels(GO:0036295) |
| 0.0 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.1 |
GO:0042094 |
interleukin-2 biosynthetic process(GO:0042094) |
| 0.0 |
0.1 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.0 |
0.0 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.0 |
0.0 |
GO:0072182 |
nephron tubule epithelial cell differentiation(GO:0072160) regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
| 0.0 |
0.1 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.0 |
0.7 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
5.5 |
GO:0006955 |
immune response(GO:0006955) |
| 0.0 |
0.1 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.0 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.0 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.0 |
0.1 |
GO:1902275 |
regulation of chromatin organization(GO:1902275) |
| 0.0 |
0.0 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.0 |
0.0 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.4 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.0 |
GO:0046348 |
amino sugar catabolic process(GO:0046348) |
| 0.0 |
0.0 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.0 |
GO:0033386 |
geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
